nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftriaxone—ALB—stomach cancer	0.331	1	CbGaD
Ceftriaxone—SLC22A11—Methotrexate—stomach cancer	0.0955	0.277	CbGbCtD
Ceftriaxone—ALB—Irinotecan—stomach cancer	0.0623	0.181	CbGbCtD
Ceftriaxone—ALB—Fluorouracil—stomach cancer	0.0598	0.173	CbGbCtD
Ceftriaxone—SLC22A8—Methotrexate—stomach cancer	0.0556	0.161	CbGbCtD
Ceftriaxone—SLC22A6—Methotrexate—stomach cancer	0.0387	0.112	CbGbCtD
Ceftriaxone—ALB—Methotrexate—stomach cancer	0.033	0.0956	CbGbCtD
Ceftriaxone—GLUL—gall bladder—stomach cancer	0.00511	0.112	CbGeAlD
Ceftriaxone—ALB—gall bladder—stomach cancer	0.00316	0.0693	CbGeAlD
Ceftriaxone—GLUL—hematopoietic system—stomach cancer	0.00289	0.0634	CbGeAlD
Ceftriaxone—GLUL—epithelium—stomach cancer	0.00264	0.0579	CbGeAlD
Ceftriaxone—GLUL—smooth muscle tissue—stomach cancer	0.00255	0.0558	CbGeAlD
Ceftriaxone—GLUL—pancreas—stomach cancer	0.00235	0.0516	CbGeAlD
Ceftriaxone—SLC15A1—epithelium—stomach cancer	0.00218	0.0479	CbGeAlD
Ceftriaxone—SLC22A11—digestive system—stomach cancer	0.00212	0.0464	CbGeAlD
Ceftriaxone—GLUL—lymphoid tissue—stomach cancer	0.00203	0.0446	CbGeAlD
Ceftriaxone—GLUL—digestive system—stomach cancer	0.00201	0.0441	CbGeAlD
Ceftriaxone—GLUL—bone marrow—stomach cancer	0.00185	0.0406	CbGeAlD
Ceftriaxone—SLC22A11—endocrine gland—stomach cancer	0.00175	0.0384	CbGeAlD
Ceftriaxone—SLC22A8—hematopoietic system—stomach cancer	0.00172	0.0377	CbGeAlD
Ceftriaxone—SLC15A1—digestive system—stomach cancer	0.00166	0.0364	CbGeAlD
Ceftriaxone—GLUL—endocrine gland—stomach cancer	0.00166	0.0364	CbGeAlD
Ceftriaxone—SLC22A11—liver—stomach cancer	0.00158	0.0346	CbGeAlD
Ceftriaxone—GLUL—liver—stomach cancer	0.0015	0.0328	CbGeAlD
Ceftriaxone—SLC15A1—endocrine gland—stomach cancer	0.00137	0.0301	CbGeAlD
Ceftriaxone—SLC15A1—liver—stomach cancer	0.00124	0.0271	CbGeAlD
Ceftriaxone—GLUL—lymph node—stomach cancer	0.00115	0.0252	CbGeAlD
Ceftriaxone—ALB—liver—stomach cancer	0.000927	0.0203	CbGeAlD
Ceftriaxone—SLC15A2—endocrine gland—stomach cancer	0.000858	0.0188	CbGeAlD
Ceftriaxone—ALB—lymph node—stomach cancer	0.000711	0.0156	CbGeAlD
Ceftriaxone—SLC15A2—lymph node—stomach cancer	0.000593	0.013	CbGeAlD
Ceftriaxone—Cefotetan—ALB—stomach cancer	0.000439	0.267	CrCbGaD
Ceftriaxone—Cefpiramide—ALB—stomach cancer	0.000382	0.232	CrCbGaD
Ceftriaxone—Thrombocytopenia—Irinotecan—stomach cancer	0.000371	0.00164	CcSEcCtD
Ceftriaxone—Haemoglobin—Docetaxel—stomach cancer	0.00037	0.00163	CcSEcCtD
Ceftriaxone—Haemorrhage—Docetaxel—stomach cancer	0.000369	0.00162	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Irinotecan—stomach cancer	0.000366	0.00161	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Fluorouracil—stomach cancer	0.000363	0.0016	CcSEcCtD
Ceftriaxone—Oedema—Fluorouracil—stomach cancer	0.000363	0.0016	CcSEcCtD
Ceftriaxone—Ataxia—Methotrexate—stomach cancer	0.000361	0.00159	CcSEcCtD
Ceftriaxone—Infection—Fluorouracil—stomach cancer	0.00036	0.00159	CcSEcCtD
Ceftriaxone—Haemoglobin—Capecitabine—stomach cancer	0.000359	0.00158	CcSEcCtD
Ceftriaxone—Haemorrhage—Capecitabine—stomach cancer	0.000357	0.00157	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Fluorouracil—stomach cancer	0.000355	0.00157	CcSEcCtD
Ceftriaxone—Dermatitis exfoliative—Doxorubicin—stomach cancer	0.000352	0.00155	CcSEcCtD
Ceftriaxone—Renal impairment—Doxorubicin—stomach cancer	0.000349	0.00154	CcSEcCtD
Ceftriaxone—Erythema multiforme—Docetaxel—stomach cancer	0.000349	0.00154	CcSEcCtD
Ceftriaxone—Toxic epidermal necrolysis—Methotrexate—stomach cancer	0.000346	0.00152	CcSEcCtD
Ceftriaxone—Anaphylactoid reaction—Doxorubicin—stomach cancer	0.000344	0.00151	CcSEcCtD
Ceftriaxone—Flushing—Docetaxel—stomach cancer	0.000342	0.00151	CcSEcCtD
Ceftriaxone—Paraesthesia—Irinotecan—stomach cancer	0.00034	0.0015	CcSEcCtD
Ceftriaxone—Ataxia—Epirubicin—stomach cancer	0.000338	0.00149	CcSEcCtD
Ceftriaxone—Erythema multiforme—Capecitabine—stomach cancer	0.000337	0.00149	CcSEcCtD
Ceftriaxone—Blood creatinine increased—Epirubicin—stomach cancer	0.000337	0.00148	CcSEcCtD
Ceftriaxone—Dyspepsia—Irinotecan—stomach cancer	0.000333	0.00147	CcSEcCtD
Ceftriaxone—Cefonicid—ALB—stomach cancer	0.000333	0.202	CrCbGaD
Ceftriaxone—Flushing—Capecitabine—stomach cancer	0.000331	0.00146	CcSEcCtD
Ceftriaxone—Chills—Docetaxel—stomach cancer	0.000331	0.00146	CcSEcCtD
Ceftriaxone—Eosinophilia—Methotrexate—stomach cancer	0.000329	0.00145	CcSEcCtD
Ceftriaxone—Abdominal pain upper—Epirubicin—stomach cancer	0.000328	0.00145	CcSEcCtD
Ceftriaxone—Paraesthesia—Fluorouracil—stomach cancer	0.000326	0.00144	CcSEcCtD
Ceftriaxone—Pancreatitis—Methotrexate—stomach cancer	0.000325	0.00143	CcSEcCtD
Ceftriaxone—Pain—Irinotecan—stomach cancer	0.000324	0.00143	CcSEcCtD
Ceftriaxone—Toxic epidermal necrolysis—Epirubicin—stomach cancer	0.000324	0.00143	CcSEcCtD
Ceftriaxone—Aspartate aminotransferase increased—Epirubicin—stomach cancer	0.000324	0.00143	CcSEcCtD
Ceftriaxone—Chills—Capecitabine—stomach cancer	0.00032	0.00141	CcSEcCtD
Ceftriaxone—Dyspepsia—Fluorouracil—stomach cancer	0.000319	0.00141	CcSEcCtD
Ceftriaxone—Dysgeusia—Docetaxel—stomach cancer	0.000314	0.00139	CcSEcCtD
Ceftriaxone—Ataxia—Doxorubicin—stomach cancer	0.000313	0.00138	CcSEcCtD
Ceftriaxone—Feeling abnormal—Irinotecan—stomach cancer	0.000312	0.00138	CcSEcCtD
Ceftriaxone—Blood creatinine increased—Doxorubicin—stomach cancer	0.000312	0.00137	CcSEcCtD
Ceftriaxone—Neutropenia—Methotrexate—stomach cancer	0.00031	0.00137	CcSEcCtD
Ceftriaxone—Pain—Fluorouracil—stomach cancer	0.00031	0.00137	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Irinotecan—stomach cancer	0.00031	0.00137	CcSEcCtD
Ceftriaxone—Eosinophilia—Epirubicin—stomach cancer	0.000308	0.00136	CcSEcCtD
Ceftriaxone—Flatulence—Capecitabine—stomach cancer	0.000306	0.00135	CcSEcCtD
Ceftriaxone—Pancreatitis—Epirubicin—stomach cancer	0.000305	0.00134	CcSEcCtD
Ceftriaxone—Dysgeusia—Capecitabine—stomach cancer	0.000304	0.00134	CcSEcCtD
Ceftriaxone—Abdominal pain upper—Doxorubicin—stomach cancer	0.000304	0.00134	CcSEcCtD
Ceftriaxone—Abdominal pain—Irinotecan—stomach cancer	0.000299	0.00132	CcSEcCtD
Ceftriaxone—Body temperature increased—Irinotecan—stomach cancer	0.000299	0.00132	CcSEcCtD
Ceftriaxone—Toxic epidermal necrolysis—Doxorubicin—stomach cancer	0.000299	0.00132	CcSEcCtD
Ceftriaxone—Aspartate aminotransferase increased—Doxorubicin—stomach cancer	0.000299	0.00132	CcSEcCtD
Ceftriaxone—Feeling abnormal—Fluorouracil—stomach cancer	0.000299	0.00132	CcSEcCtD
Ceftriaxone—GLUL—Neuronal System—HSPA8—stomach cancer	0.000299	0.006	CbGpPWpGaD
Ceftriaxone—Anaemia—Docetaxel—stomach cancer	0.000297	0.00131	CcSEcCtD
Ceftriaxone—ALB—FOXA2 and FOXA3 transcription factor networks—ALDOB—stomach cancer	0.000295	0.00591	CbGpPWpGaD
Ceftriaxone—Stevens-Johnson syndrome—Methotrexate—stomach cancer	0.000293	0.00129	CcSEcCtD
Ceftriaxone—ALB—HDL-mediated lipid transport—APOA1—stomach cancer	0.000292	0.00586	CbGpPWpGaD
Ceftriaxone—Renal failure—Methotrexate—stomach cancer	0.000291	0.00128	CcSEcCtD
Ceftriaxone—Neutropenia—Epirubicin—stomach cancer	0.00029	0.00128	CcSEcCtD
Ceftriaxone—GLUL—Metabolism—ACAD8—stomach cancer	0.000289	0.00581	CbGpPWpGaD
Ceftriaxone—Stomatitis—Methotrexate—stomach cancer	0.000288	0.00127	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Capecitabine—stomach cancer	0.000288	0.00127	CcSEcCtD
Ceftriaxone—Urticaria—Fluorouracil—stomach cancer	0.000288	0.00127	CcSEcCtD
Ceftriaxone—Leukopenia—Docetaxel—stomach cancer	0.000287	0.00127	CcSEcCtD
Ceftriaxone—Anaemia—Capecitabine—stomach cancer	0.000287	0.00127	CcSEcCtD
Ceftriaxone—Body temperature increased—Fluorouracil—stomach cancer	0.000287	0.00126	CcSEcCtD
Ceftriaxone—Eosinophilia—Doxorubicin—stomach cancer	0.000285	0.00125	CcSEcCtD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—CLCN3—stomach cancer	0.000284	0.00571	CbGpPWpGaD
Ceftriaxone—Palpitations—Docetaxel—stomach cancer	0.000284	0.00125	CcSEcCtD
Ceftriaxone—Haematuria—Methotrexate—stomach cancer	0.000282	0.00124	CcSEcCtD
Ceftriaxone—Pancreatitis—Doxorubicin—stomach cancer	0.000282	0.00124	CcSEcCtD
Ceftriaxone—Malaise—Capecitabine—stomach cancer	0.00028	0.00123	CcSEcCtD
Ceftriaxone—Epistaxis—Methotrexate—stomach cancer	0.000279	0.00123	CcSEcCtD
Ceftriaxone—Hypersensitivity—Irinotecan—stomach cancer	0.000279	0.00123	CcSEcCtD
Ceftriaxone—Leukopenia—Capecitabine—stomach cancer	0.000278	0.00123	CcSEcCtD
Ceftriaxone—Convulsion—Docetaxel—stomach cancer	0.000278	0.00123	CcSEcCtD
Ceftriaxone—Agranulocytosis—Methotrexate—stomach cancer	0.000276	0.00122	CcSEcCtD
Ceftriaxone—Stevens-Johnson syndrome—Epirubicin—stomach cancer	0.000275	0.00121	CcSEcCtD
Ceftriaxone—Palpitations—Capecitabine—stomach cancer	0.000275	0.00121	CcSEcCtD
Ceftriaxone—Renal failure—Epirubicin—stomach cancer	0.000272	0.0012	CcSEcCtD
Ceftriaxone—Jaundice—Epirubicin—stomach cancer	0.00027	0.00119	CcSEcCtD
Ceftriaxone—Stomatitis—Epirubicin—stomach cancer	0.00027	0.00119	CcSEcCtD
Ceftriaxone—ALB—Bile acid and bile salt metabolism—AKR1C3—stomach cancer	0.000269	0.0054	CbGpPWpGaD
Ceftriaxone—Neutropenia—Doxorubicin—stomach cancer	0.000269	0.00118	CcSEcCtD
Ceftriaxone—Hypersensitivity—Fluorouracil—stomach cancer	0.000267	0.00118	CcSEcCtD
Ceftriaxone—Haemoglobin—Methotrexate—stomach cancer	0.000267	0.00118	CcSEcCtD
Ceftriaxone—Haemorrhage—Methotrexate—stomach cancer	0.000266	0.00117	CcSEcCtD
Ceftriaxone—Haematuria—Epirubicin—stomach cancer	0.000264	0.00116	CcSEcCtD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—CLCN3—stomach cancer	0.000264	0.0053	CbGpPWpGaD
Ceftriaxone—SLC22A11—SLC-mediated transmembrane transport—SLC1A2—stomach cancer	0.000264	0.00529	CbGpPWpGaD
Ceftriaxone—Anaphylactic shock—Docetaxel—stomach cancer	0.000262	0.00115	CcSEcCtD
Ceftriaxone—Oedema—Docetaxel—stomach cancer	0.000262	0.00115	CcSEcCtD
Ceftriaxone—Discomfort—Capecitabine—stomach cancer	0.000261	0.00115	CcSEcCtD
Ceftriaxone—Epistaxis—Epirubicin—stomach cancer	0.000261	0.00115	CcSEcCtD
Ceftriaxone—Infection—Docetaxel—stomach cancer	0.00026	0.00115	CcSEcCtD
Ceftriaxone—GLUL—TNF alpha Signaling Pathway—JUN—stomach cancer	0.000259	0.00521	CbGpPWpGaD
Ceftriaxone—Diarrhoea—Irinotecan—stomach cancer	0.000259	0.00114	CcSEcCtD
Ceftriaxone—Agranulocytosis—Epirubicin—stomach cancer	0.000258	0.00114	CcSEcCtD
Ceftriaxone—GLUL—Metabolism—GMPR2—stomach cancer	0.000258	0.00518	CbGpPWpGaD
Ceftriaxone—Pruritus—Fluorouracil—stomach cancer	0.000257	0.00113	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Docetaxel—stomach cancer	0.000256	0.00113	CcSEcCtD
Ceftriaxone—Stevens-Johnson syndrome—Doxorubicin—stomach cancer	0.000254	0.00112	CcSEcCtD
Ceftriaxone—Oedema—Capecitabine—stomach cancer	0.000254	0.00112	CcSEcCtD
Ceftriaxone—Renal failure—Doxorubicin—stomach cancer	0.000252	0.00111	CcSEcCtD
Ceftriaxone—Infection—Capecitabine—stomach cancer	0.000252	0.00111	CcSEcCtD
Ceftriaxone—Erythema multiforme—Methotrexate—stomach cancer	0.000251	0.00111	CcSEcCtD
Ceftriaxone—Dizziness—Irinotecan—stomach cancer	0.000251	0.0011	CcSEcCtD
Ceftriaxone—Haemoglobin—Epirubicin—stomach cancer	0.00025	0.0011	CcSEcCtD
Ceftriaxone—Jaundice—Doxorubicin—stomach cancer	0.00025	0.0011	CcSEcCtD
Ceftriaxone—Stomatitis—Doxorubicin—stomach cancer	0.00025	0.0011	CcSEcCtD
Ceftriaxone—Haemorrhage—Epirubicin—stomach cancer	0.000249	0.0011	CcSEcCtD
Ceftriaxone—Diarrhoea—Fluorouracil—stomach cancer	0.000248	0.00109	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Capecitabine—stomach cancer	0.000248	0.00109	CcSEcCtD
Ceftriaxone—ALB—Binding and Uptake of Ligands by Scavenger Receptors—SPARC—stomach cancer	0.000246	0.00494	CbGpPWpGaD
Ceftriaxone—GLUL—TNF alpha Signaling Pathway—MAPK8—stomach cancer	0.000246	0.00493	CbGpPWpGaD
Ceftriaxone—Hyperhidrosis—Capecitabine—stomach cancer	0.000245	0.00108	CcSEcCtD
Ceftriaxone—Haematuria—Doxorubicin—stomach cancer	0.000244	0.00108	CcSEcCtD
Ceftriaxone—SLC15A2—SLC-mediated transmembrane transport—SLC1A2—stomach cancer	0.000244	0.00489	CbGpPWpGaD
Ceftriaxone—Epistaxis—Doxorubicin—stomach cancer	0.000242	0.00107	CcSEcCtD
Ceftriaxone—Vomiting—Irinotecan—stomach cancer	0.000241	0.00106	CcSEcCtD
Ceftriaxone—Dizziness—Fluorouracil—stomach cancer	0.00024	0.00106	CcSEcCtD
Ceftriaxone—Agranulocytosis—Doxorubicin—stomach cancer	0.000239	0.00105	CcSEcCtD
Ceftriaxone—Rash—Irinotecan—stomach cancer	0.000239	0.00105	CcSEcCtD
Ceftriaxone—Dermatitis—Irinotecan—stomach cancer	0.000239	0.00105	CcSEcCtD
Ceftriaxone—Chills—Methotrexate—stomach cancer	0.000238	0.00105	CcSEcCtD
Ceftriaxone—Headache—Irinotecan—stomach cancer	0.000237	0.00105	CcSEcCtD
Ceftriaxone—GLUL—Metabolism—SUCLG1—stomach cancer	0.000236	0.00474	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—IDH3B—stomach cancer	0.000236	0.00474	CbGpPWpGaD
Ceftriaxone—Paraesthesia—Docetaxel—stomach cancer	0.000235	0.00104	CcSEcCtD
Ceftriaxone—Erythema multiforme—Epirubicin—stomach cancer	0.000235	0.00104	CcSEcCtD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—CLCN3—stomach cancer	0.000235	0.00471	CbGpPWpGaD
Ceftriaxone—Haemoglobin—Doxorubicin—stomach cancer	0.000231	0.00102	CcSEcCtD
Ceftriaxone—Flushing—Epirubicin—stomach cancer	0.000231	0.00102	CcSEcCtD
Ceftriaxone—Vomiting—Fluorouracil—stomach cancer	0.000231	0.00102	CcSEcCtD
Ceftriaxone—Dyspepsia—Docetaxel—stomach cancer	0.000231	0.00102	CcSEcCtD
Ceftriaxone—Haemorrhage—Doxorubicin—stomach cancer	0.00023	0.00101	CcSEcCtD
Ceftriaxone—Rash—Fluorouracil—stomach cancer	0.000229	0.00101	CcSEcCtD
Ceftriaxone—Dermatitis—Fluorouracil—stomach cancer	0.000229	0.00101	CcSEcCtD
Ceftriaxone—Paraesthesia—Capecitabine—stomach cancer	0.000228	0.001	CcSEcCtD
Ceftriaxone—Headache—Fluorouracil—stomach cancer	0.000227	0.001	CcSEcCtD
Ceftriaxone—Dysgeusia—Methotrexate—stomach cancer	0.000226	0.000998	CcSEcCtD
Ceftriaxone—SLC15A1—SLC-mediated transmembrane transport—SLC1A2—stomach cancer	0.000226	0.00454	CbGpPWpGaD
Ceftriaxone—Nausea—Irinotecan—stomach cancer	0.000225	0.000992	CcSEcCtD
Ceftriaxone—Pain—Docetaxel—stomach cancer	0.000224	0.000987	CcSEcCtD
Ceftriaxone—Dyspepsia—Capecitabine—stomach cancer	0.000223	0.000984	CcSEcCtD
Ceftriaxone—Chills—Epirubicin—stomach cancer	0.000223	0.000983	CcSEcCtD
Ceftriaxone—GLUL—Metabolism—NDUFV1—stomach cancer	0.000219	0.0044	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—NDUFS1—stomach cancer	0.000219	0.0044	CbGpPWpGaD
Ceftriaxone—Erythema multiforme—Doxorubicin—stomach cancer	0.000218	0.000959	CcSEcCtD
Ceftriaxone—Pain—Capecitabine—stomach cancer	0.000217	0.000956	CcSEcCtD
Ceftriaxone—Feeling abnormal—Docetaxel—stomach cancer	0.000216	0.000951	CcSEcCtD
Ceftriaxone—Nausea—Fluorouracil—stomach cancer	0.000216	0.00095	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Methotrexate—stomach cancer	0.000215	0.000946	CcSEcCtD
Ceftriaxone—GLUL—TNF alpha Signaling Pathway—MAPK3—stomach cancer	0.000214	0.0043	CbGpPWpGaD
Ceftriaxone—Gastrointestinal pain—Docetaxel—stomach cancer	0.000214	0.000944	CcSEcCtD
Ceftriaxone—Anaemia—Methotrexate—stomach cancer	0.000214	0.000942	CcSEcCtD
Ceftriaxone—Flushing—Doxorubicin—stomach cancer	0.000213	0.000941	CcSEcCtD
Ceftriaxone—Flatulence—Epirubicin—stomach cancer	0.000213	0.00094	CcSEcCtD
Ceftriaxone—GLUL—Transmission across Chemical Synapses—PRKCB—stomach cancer	0.000213	0.00427	CbGpPWpGaD
Ceftriaxone—Dysgeusia—Epirubicin—stomach cancer	0.000212	0.000934	CcSEcCtD
Ceftriaxone—Feeling abnormal—Capecitabine—stomach cancer	0.000209	0.000921	CcSEcCtD
Ceftriaxone—Malaise—Methotrexate—stomach cancer	0.000209	0.000919	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Capecitabine—stomach cancer	0.000207	0.000914	CcSEcCtD
Ceftriaxone—Abdominal pain—Docetaxel—stomach cancer	0.000207	0.000913	CcSEcCtD
Ceftriaxone—Body temperature increased—Docetaxel—stomach cancer	0.000207	0.000913	CcSEcCtD
Ceftriaxone—Leukopenia—Methotrexate—stomach cancer	0.000207	0.000913	CcSEcCtD
Ceftriaxone—Chills—Doxorubicin—stomach cancer	0.000206	0.00091	CcSEcCtD
Ceftriaxone—GLUL—TNF alpha Signaling Pathway—MAPK1—stomach cancer	0.000204	0.00409	CbGpPWpGaD
Ceftriaxone—Urticaria—Capecitabine—stomach cancer	0.000201	0.000888	CcSEcCtD
Ceftriaxone—SLC22A8—SLC-mediated transmembrane transport—SLC1A2—stomach cancer	0.000201	0.00403	CbGpPWpGaD
Ceftriaxone—Ill-defined disorder—Epirubicin—stomach cancer	0.000201	0.000885	CcSEcCtD
Ceftriaxone—Abdominal pain—Capecitabine—stomach cancer	0.0002	0.000884	CcSEcCtD
Ceftriaxone—Body temperature increased—Capecitabine—stomach cancer	0.0002	0.000884	CcSEcCtD
Ceftriaxone—Convulsion—Methotrexate—stomach cancer	0.0002	0.000883	CcSEcCtD
Ceftriaxone—Anaemia—Epirubicin—stomach cancer	0.0002	0.000882	CcSEcCtD
Ceftriaxone—Agitation—Epirubicin—stomach cancer	0.000199	0.000877	CcSEcCtD
Ceftriaxone—Flatulence—Doxorubicin—stomach cancer	0.000197	0.00087	CcSEcCtD
Ceftriaxone—Cefoperazone—ALB—stomach cancer	0.000196	0.119	CrCbGaD
Ceftriaxone—Dysgeusia—Doxorubicin—stomach cancer	0.000196	0.000864	CcSEcCtD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—CLCN3—stomach cancer	0.000196	0.00393	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PGLS—stomach cancer	0.000196	0.00392	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—BLVRB—stomach cancer	0.000196	0.00392	CbGpPWpGaD
Ceftriaxone—Malaise—Epirubicin—stomach cancer	0.000195	0.00086	CcSEcCtD
Ceftriaxone—Discomfort—Methotrexate—stomach cancer	0.000195	0.000858	CcSEcCtD
Ceftriaxone—GLUL—TNF alpha Signaling Pathway—TNF—stomach cancer	0.000194	0.0039	CbGpPWpGaD
Ceftriaxone—Leukopenia—Epirubicin—stomach cancer	0.000194	0.000854	CcSEcCtD
Ceftriaxone—Hypersensitivity—Docetaxel—stomach cancer	0.000193	0.000851	CcSEcCtD
Ceftriaxone—GLUL—TNF alpha Signaling Pathway—KRAS—stomach cancer	0.000193	0.00387	CbGpPWpGaD
Ceftriaxone—Palpitations—Epirubicin—stomach cancer	0.000191	0.000843	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Methotrexate—stomach cancer	0.000189	0.000832	CcSEcCtD
Ceftriaxone—Convulsion—Epirubicin—stomach cancer	0.000188	0.000827	CcSEcCtD
Ceftriaxone—Infection—Methotrexate—stomach cancer	0.000188	0.000827	CcSEcCtD
Ceftriaxone—Hypersensitivity—Capecitabine—stomach cancer	0.000187	0.000823	CcSEcCtD
Ceftriaxone—GLUL—Metabolism—PPAP2A—stomach cancer	0.000187	0.00374	CbGpPWpGaD
Ceftriaxone—Ill-defined disorder—Doxorubicin—stomach cancer	0.000186	0.000819	CcSEcCtD
Ceftriaxone—Pruritus—Docetaxel—stomach cancer	0.000185	0.000817	CcSEcCtD
Ceftriaxone—Anaemia—Doxorubicin—stomach cancer	0.000185	0.000816	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Methotrexate—stomach cancer	0.000185	0.000815	CcSEcCtD
Ceftriaxone—Agitation—Doxorubicin—stomach cancer	0.000184	0.000811	CcSEcCtD
Ceftriaxone—ALB—Platelet degranulation—FGG—stomach cancer	0.000183	0.00366	CbGpPWpGaD
Ceftriaxone—Hyperhidrosis—Methotrexate—stomach cancer	0.000182	0.000804	CcSEcCtD
Ceftriaxone—Discomfort—Epirubicin—stomach cancer	0.000182	0.000803	CcSEcCtD
Ceftriaxone—Malaise—Doxorubicin—stomach cancer	0.000181	0.000796	CcSEcCtD
Ceftriaxone—Pruritus—Capecitabine—stomach cancer	0.000179	0.000791	CcSEcCtD
Ceftriaxone—Leukopenia—Doxorubicin—stomach cancer	0.000179	0.00079	CcSEcCtD
Ceftriaxone—Diarrhoea—Docetaxel—stomach cancer	0.000179	0.00079	CcSEcCtD
Ceftriaxone—Palpitations—Doxorubicin—stomach cancer	0.000177	0.00078	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Epirubicin—stomach cancer	0.000177	0.000779	CcSEcCtD
Ceftriaxone—Oedema—Epirubicin—stomach cancer	0.000177	0.000779	CcSEcCtD
Ceftriaxone—Infection—Epirubicin—stomach cancer	0.000175	0.000774	CcSEcCtD
Ceftriaxone—ALB—Response to elevated platelet cytosolic Ca2+—FGG—stomach cancer	0.000174	0.00349	CbGpPWpGaD
Ceftriaxone—Convulsion—Doxorubicin—stomach cancer	0.000174	0.000765	CcSEcCtD
Ceftriaxone—Diarrhoea—Capecitabine—stomach cancer	0.000173	0.000765	CcSEcCtD
Ceftriaxone—Dizziness—Docetaxel—stomach cancer	0.000173	0.000763	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Epirubicin—stomach cancer	0.000173	0.000762	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Epirubicin—stomach cancer	0.000171	0.000753	CcSEcCtD
Ceftriaxone—Paraesthesia—Methotrexate—stomach cancer	0.000169	0.000747	CcSEcCtD
Ceftriaxone—Discomfort—Doxorubicin—stomach cancer	0.000168	0.000743	CcSEcCtD
Ceftriaxone—SLC22A6—SLC-mediated transmembrane transport—SLC1A2—stomach cancer	0.000168	0.00337	CbGpPWpGaD
Ceftriaxone—Dizziness—Capecitabine—stomach cancer	0.000168	0.000739	CcSEcCtD
Ceftriaxone—ALB—Lipoprotein metabolism—APOA1—stomach cancer	0.000168	0.00336	CbGpPWpGaD
Ceftriaxone—Vomiting—Docetaxel—stomach cancer	0.000167	0.000734	CcSEcCtD
Ceftriaxone—GLUL—Metabolism—CA1—stomach cancer	0.000166	0.00334	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—CKB—stomach cancer	0.000166	0.00334	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—FBP1—stomach cancer	0.000166	0.00334	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—NDUFA2—stomach cancer	0.000166	0.00334	CbGpPWpGaD
Ceftriaxone—Dyspepsia—Methotrexate—stomach cancer	0.000166	0.000732	CcSEcCtD
Ceftriaxone—ALB—Platelet degranulation—PPIA—stomach cancer	0.000166	0.00332	CbGpPWpGaD
Ceftriaxone—Rash—Docetaxel—stomach cancer	0.000165	0.000728	CcSEcCtD
Ceftriaxone—Dermatitis—Docetaxel—stomach cancer	0.000165	0.000727	CcSEcCtD
Ceftriaxone—Headache—Docetaxel—stomach cancer	0.000164	0.000723	CcSEcCtD
Ceftriaxone—GLUL—TNF alpha Signaling Pathway—HRAS—stomach cancer	0.000164	0.00329	CbGpPWpGaD
Ceftriaxone—Oedema—Doxorubicin—stomach cancer	0.000163	0.00072	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Doxorubicin—stomach cancer	0.000163	0.00072	CcSEcCtD
Ceftriaxone—GLUL—Neuronal System—PRKCB—stomach cancer	0.000163	0.00327	CbGpPWpGaD
Ceftriaxone—Infection—Doxorubicin—stomach cancer	0.000162	0.000716	CcSEcCtD
Ceftriaxone—Pain—Methotrexate—stomach cancer	0.000161	0.000712	CcSEcCtD
Ceftriaxone—Vomiting—Capecitabine—stomach cancer	0.000161	0.000711	CcSEcCtD
Ceftriaxone—Cefazolin—ALB—stomach cancer	0.000161	0.098	CrCbGaD
Ceftriaxone—Thrombocytopenia—Doxorubicin—stomach cancer	0.00016	0.000705	CcSEcCtD
Ceftriaxone—Rash—Capecitabine—stomach cancer	0.00016	0.000705	CcSEcCtD
Ceftriaxone—Dermatitis—Capecitabine—stomach cancer	0.00016	0.000704	CcSEcCtD
Ceftriaxone—ALB—Platelet degranulation—SERPINA1—stomach cancer	0.00016	0.0032	CbGpPWpGaD
Ceftriaxone—Headache—Capecitabine—stomach cancer	0.000159	0.0007	CcSEcCtD
Ceftriaxone—Paraesthesia—Epirubicin—stomach cancer	0.000159	0.000699	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Doxorubicin—stomach cancer	0.000158	0.000696	CcSEcCtD
Ceftriaxone—ALB—Response to elevated platelet cytosolic Ca2+—PPIA—stomach cancer	0.000158	0.00317	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—ALOX5—stomach cancer	0.000157	0.00316	CbGpPWpGaD
Ceftriaxone—GLUL—TNF alpha Signaling Pathway—IL6—stomach cancer	0.000157	0.00315	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PLIN2—stomach cancer	0.000156	0.00314	CbGpPWpGaD
Ceftriaxone—Nausea—Docetaxel—stomach cancer	0.000156	0.000686	CcSEcCtD
Ceftriaxone—Feeling abnormal—Methotrexate—stomach cancer	0.000156	0.000686	CcSEcCtD
Ceftriaxone—Dyspepsia—Epirubicin—stomach cancer	0.000155	0.000685	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Methotrexate—stomach cancer	0.000154	0.00068	CcSEcCtD
Ceftriaxone—GLUL—Metabolism—CA2—stomach cancer	0.000152	0.00305	CbGpPWpGaD
Ceftriaxone—ALB—Response to elevated platelet cytosolic Ca2+—SERPINA1—stomach cancer	0.000152	0.00305	CbGpPWpGaD
Ceftriaxone—Pain—Epirubicin—stomach cancer	0.000151	0.000666	CcSEcCtD
Ceftriaxone—Nausea—Capecitabine—stomach cancer	0.000151	0.000664	CcSEcCtD
Ceftriaxone—Urticaria—Methotrexate—stomach cancer	0.00015	0.000661	CcSEcCtD
Ceftriaxone—Body temperature increased—Methotrexate—stomach cancer	0.000149	0.000658	CcSEcCtD
Ceftriaxone—Abdominal pain—Methotrexate—stomach cancer	0.000149	0.000658	CcSEcCtD
Ceftriaxone—GLUL—Metabolism—NT5E—stomach cancer	0.000148	0.00297	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PGAM1—stomach cancer	0.000148	0.00297	CbGpPWpGaD
Ceftriaxone—Paraesthesia—Doxorubicin—stomach cancer	0.000147	0.000647	CcSEcCtD
Ceftriaxone—Feeling abnormal—Epirubicin—stomach cancer	0.000146	0.000642	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Epirubicin—stomach cancer	0.000144	0.000637	CcSEcCtD
Ceftriaxone—ALB—Platelet degranulation—SPARC—stomach cancer	0.000144	0.0029	CbGpPWpGaD
Ceftriaxone—Dyspepsia—Doxorubicin—stomach cancer	0.000144	0.000634	CcSEcCtD
Ceftriaxone—GLUL—Metabolism—ALDH7A1—stomach cancer	0.000141	0.00284	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PLCE1—stomach cancer	0.000141	0.00284	CbGpPWpGaD
Ceftriaxone—Urticaria—Epirubicin—stomach cancer	0.00014	0.000619	CcSEcCtD
Ceftriaxone—Pain—Doxorubicin—stomach cancer	0.00014	0.000616	CcSEcCtD
Ceftriaxone—Body temperature increased—Epirubicin—stomach cancer	0.00014	0.000616	CcSEcCtD
Ceftriaxone—Abdominal pain—Epirubicin—stomach cancer	0.00014	0.000616	CcSEcCtD
Ceftriaxone—Hypersensitivity—Methotrexate—stomach cancer	0.000139	0.000613	CcSEcCtD
Ceftriaxone—ALB—Response to elevated platelet cytosolic Ca2+—SPARC—stomach cancer	0.000137	0.00276	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—UMPS—stomach cancer	0.000136	0.00272	CbGpPWpGaD
Ceftriaxone—ALB—Vitamin B12 Metabolism—SOD2—stomach cancer	0.000135	0.00272	CbGpPWpGaD
Ceftriaxone—Feeling abnormal—Doxorubicin—stomach cancer	0.000135	0.000594	CcSEcCtD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—SLC1A2—stomach cancer	0.000134	0.00269	CbGpPWpGaD
Ceftriaxone—Cefalotin—ALB—stomach cancer	0.000134	0.0814	CrCbGaD
Ceftriaxone—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000134	0.000589	CcSEcCtD
Ceftriaxone—Pruritus—Methotrexate—stomach cancer	0.000134	0.000589	CcSEcCtD
Ceftriaxone—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOA1—stomach cancer	0.000131	0.00262	CbGpPWpGaD
Ceftriaxone—Hypersensitivity—Epirubicin—stomach cancer	0.00013	0.000574	CcSEcCtD
Ceftriaxone—Urticaria—Doxorubicin—stomach cancer	0.00013	0.000572	CcSEcCtD
Ceftriaxone—Body temperature increased—Doxorubicin—stomach cancer	0.000129	0.00057	CcSEcCtD
Ceftriaxone—Abdominal pain—Doxorubicin—stomach cancer	0.000129	0.00057	CcSEcCtD
Ceftriaxone—Diarrhoea—Methotrexate—stomach cancer	0.000129	0.000569	CcSEcCtD
Ceftriaxone—GLUL—Metabolism—ECHS1—stomach cancer	0.000126	0.00253	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PDHA1—stomach cancer	0.000126	0.00253	CbGpPWpGaD
Ceftriaxone—Pruritus—Epirubicin—stomach cancer	0.000125	0.000551	CcSEcCtD
Ceftriaxone—Dizziness—Methotrexate—stomach cancer	0.000125	0.00055	CcSEcCtD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—SLC1A2—stomach cancer	0.000124	0.00248	CbGpPWpGaD
Ceftriaxone—ALB—FOXA2 and FOXA3 transcription factor networks—APOA1—stomach cancer	0.000123	0.00248	CbGpPWpGaD
Ceftriaxone—Diarrhoea—Epirubicin—stomach cancer	0.000121	0.000533	CcSEcCtD
Ceftriaxone—Hypersensitivity—Doxorubicin—stomach cancer	0.00012	0.000531	CcSEcCtD
Ceftriaxone—Vomiting—Methotrexate—stomach cancer	0.00012	0.000529	CcSEcCtD
Ceftriaxone—ALB—Vitamin B12 Metabolism—MTHFR—stomach cancer	0.000119	0.00239	CbGpPWpGaD
Ceftriaxone—Rash—Methotrexate—stomach cancer	0.000119	0.000525	CcSEcCtD
Ceftriaxone—Dermatitis—Methotrexate—stomach cancer	0.000119	0.000524	CcSEcCtD
Ceftriaxone—GLUL—Metabolism—TYMP—stomach cancer	0.000118	0.00238	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—FADS1—stomach cancer	0.000118	0.00238	CbGpPWpGaD
Ceftriaxone—Headache—Methotrexate—stomach cancer	0.000118	0.000521	CcSEcCtD
Ceftriaxone—Dizziness—Epirubicin—stomach cancer	0.000117	0.000515	CcSEcCtD
Ceftriaxone—Pruritus—Doxorubicin—stomach cancer	0.000116	0.00051	CcSEcCtD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—SLC1A2—stomach cancer	0.000115	0.00231	CbGpPWpGaD
Ceftriaxone—Vomiting—Epirubicin—stomach cancer	0.000112	0.000495	CcSEcCtD
Ceftriaxone—Nausea—Methotrexate—stomach cancer	0.000112	0.000494	CcSEcCtD
Ceftriaxone—Diarrhoea—Doxorubicin—stomach cancer	0.000112	0.000493	CcSEcCtD
Ceftriaxone—ALB—Lipid and lipoprotein metabolism—CAV1—stomach cancer	0.000112	0.00224	CbGpPWpGaD
Ceftriaxone—ALB—Lipid and lipoprotein metabolism—APOA1—stomach cancer	0.000111	0.00224	CbGpPWpGaD
Ceftriaxone—Rash—Epirubicin—stomach cancer	0.000111	0.000491	CcSEcCtD
Ceftriaxone—Dermatitis—Epirubicin—stomach cancer	0.000111	0.00049	CcSEcCtD
Ceftriaxone—GLUL—Metabolism—SREBF2—stomach cancer	0.000111	0.00223	CbGpPWpGaD
Ceftriaxone—Headache—Epirubicin—stomach cancer	0.000111	0.000488	CcSEcCtD
Ceftriaxone—ALB—Folate Metabolism—SOD2—stomach cancer	0.00011	0.00221	CbGpPWpGaD
Ceftriaxone—ALB—Vitamin B12 Metabolism—APOA1—stomach cancer	0.00011	0.0022	CbGpPWpGaD
Ceftriaxone—GLUL—Transmission across Chemical Synapses—MAPK1—stomach cancer	0.00011	0.0022	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—RORA—stomach cancer	0.00011	0.0022	CbGpPWpGaD
Ceftriaxone—Dizziness—Doxorubicin—stomach cancer	0.000108	0.000476	CcSEcCtD
Ceftriaxone—Nausea—Epirubicin—stomach cancer	0.000105	0.000463	CcSEcCtD
Ceftriaxone—Vomiting—Doxorubicin—stomach cancer	0.000104	0.000458	CcSEcCtD
Ceftriaxone—Rash—Doxorubicin—stomach cancer	0.000103	0.000454	CcSEcCtD
Ceftriaxone—Dermatitis—Doxorubicin—stomach cancer	0.000103	0.000454	CcSEcCtD
Ceftriaxone—GLUL—Metabolism—ALDOB—stomach cancer	0.000103	0.00206	CbGpPWpGaD
Ceftriaxone—Headache—Doxorubicin—stomach cancer	0.000102	0.000451	CcSEcCtD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—SLC1A2—stomach cancer	0.000102	0.00205	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—CLCN3—stomach cancer	0.000102	0.00204	CbGpPWpGaD
Ceftriaxone—Nausea—Doxorubicin—stomach cancer	9.71e-05	0.000428	CcSEcCtD
Ceftriaxone—ALB—Folate Metabolism—MTHFR—stomach cancer	9.7e-05	0.00195	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—ALOX5—stomach cancer	9.55e-05	0.00192	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—DPYD—stomach cancer	9.4e-05	0.00189	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—APOA1—stomach cancer	8.92e-05	0.00179	CbGpPWpGaD
Ceftriaxone—GLUL—Transmission across Chemical Synapses—HRAS—stomach cancer	8.8e-05	0.00177	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—SOD2—stomach cancer	8.75e-05	0.00176	CbGpPWpGaD
Ceftriaxone—ALB—SLC-mediated transmembrane transport—SLC1A2—stomach cancer	8.72e-05	0.00175	CbGpPWpGaD
Ceftriaxone—ALB—Vitamin B12 Metabolism—SERPINE1—stomach cancer	8.71e-05	0.00175	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—SLC1A2—stomach cancer	8.53e-05	0.00171	CbGpPWpGaD
Ceftriaxone—GLUL—Neuronal System—MAPK1—stomach cancer	8.4e-05	0.00169	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—GSTT1—stomach cancer	8.31e-05	0.00167	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—CYP2A6—stomach cancer	8.21e-05	0.00165	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—FGG—stomach cancer	8.1e-05	0.00162	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—AKR1C3—stomach cancer	7.99e-05	0.0016	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—ENO1—stomach cancer	7.78e-05	0.00156	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—MTHFR—stomach cancer	7.7e-05	0.00155	CbGpPWpGaD
Ceftriaxone—ALB—Platelet degranulation—APOA1—stomach cancer	7.65e-05	0.00153	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—PPIA—stomach cancer	7.35e-05	0.00147	CbGpPWpGaD
Ceftriaxone—ALB—Response to elevated platelet cytosolic Ca2+—APOA1—stomach cancer	7.29e-05	0.00146	CbGpPWpGaD
Ceftriaxone—SLC22A11—SLC-mediated transmembrane transport—ALB—stomach cancer	7.13e-05	0.00143	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—APOA1—stomach cancer	7.09e-05	0.00142	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—SERPINE1—stomach cancer	7.08e-05	0.00142	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—SERPINA1—stomach cancer	7.08e-05	0.00142	CbGpPWpGaD
Ceftriaxone—ALB—Vitamin B12 Metabolism—IL1B—stomach cancer	7.07e-05	0.00142	CbGpPWpGaD
Ceftriaxone—ALB—Response to elevated platelet cytosolic Ca2+—PRKCB—stomach cancer	6.95e-05	0.00139	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—CD44—stomach cancer	6.9e-05	0.00139	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PPAP2A—stomach cancer	6.9e-05	0.00138	CbGpPWpGaD
Ceftriaxone—GLUL—Neuronal System—HRAS—stomach cancer	6.74e-05	0.00135	CbGpPWpGaD
Ceftriaxone—SLC15A2—SLC-mediated transmembrane transport—ALB—stomach cancer	6.59e-05	0.00132	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—F2R—stomach cancer	6.4e-05	0.00128	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—SPARC—stomach cancer	6.4e-05	0.00128	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—SERPINB2—stomach cancer	6.18e-05	0.00124	CbGpPWpGaD
Ceftriaxone—SLC15A1—SLC-mediated transmembrane transport—ALB—stomach cancer	6.12e-05	0.00123	CbGpPWpGaD
Ceftriaxone—ALB—Platelet degranulation—SERPINE1—stomach cancer	6.07e-05	0.00122	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—HMOX1—stomach cancer	6.04e-05	0.00121	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PPP2R1A—stomach cancer	5.87e-05	0.00118	CbGpPWpGaD
Ceftriaxone—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—stomach cancer	5.78e-05	0.00116	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PLIN2—stomach cancer	5.78e-05	0.00116	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—GSTP1—stomach cancer	5.76e-05	0.00116	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—IL1B—stomach cancer	5.75e-05	0.00115	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—HMOX1—stomach cancer	5.68e-05	0.00114	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—SERPINE1—stomach cancer	5.63e-05	0.00113	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—HMOX1—stomach cancer	5.58e-05	0.00112	CbGpPWpGaD
Ceftriaxone—SLC22A8—SLC-mediated transmembrane transport—ALB—stomach cancer	5.44e-05	0.00109	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—TYMS—stomach cancer	5.35e-05	0.00107	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—ITGA5—stomach cancer	5.3e-05	0.00106	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—GSTM1—stomach cancer	5.29e-05	0.00106	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—HMOX1—stomach cancer	5.18e-05	0.00104	CbGpPWpGaD
Ceftriaxone—ALB—Vitamin B12 Metabolism—TNF—stomach cancer	5.13e-05	0.00103	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—ERCC2—stomach cancer	4.98e-05	0.000998	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—PTGS2—stomach cancer	4.91e-05	0.000986	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ACAD8—stomach cancer	4.77e-05	0.000957	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—MTHFR—stomach cancer	4.68e-05	0.000938	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	4.66e-05	0.000935	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—HMOX1—stomach cancer	4.61e-05	0.000924	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—APOA1—stomach cancer	4.58e-05	0.000918	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—IL1B—stomach cancer	4.57e-05	0.000917	CbGpPWpGaD
Ceftriaxone—SLC22A6—SLC-mediated transmembrane transport—ALB—stomach cancer	4.54e-05	0.000911	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—SLC1A2—stomach cancer	4.43e-05	0.000889	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	4.38e-05	0.000879	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—CAV1—stomach cancer	4.31e-05	0.000866	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—APOA1—stomach cancer	4.3e-05	0.000864	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GMPR2—stomach cancer	4.25e-05	0.000853	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—APOA1—stomach cancer	4.23e-05	0.000848	CbGpPWpGaD
Ceftriaxone—ALB—Platelet degranulation—VEGFA—stomach cancer	4.18e-05	0.000838	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—TNF—stomach cancer	4.18e-05	0.000838	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—FGG—stomach cancer	4.17e-05	0.000838	CbGpPWpGaD
Ceftriaxone—ALB—Vitamin B12 Metabolism—IL6—stomach cancer	4.14e-05	0.000831	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	4.1e-05	0.000824	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—THBD—stomach cancer	4.09e-05	0.000821	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—FYN—stomach cancer	4.08e-05	0.000819	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—RORA—stomach cancer	4.06e-05	0.000814	CbGpPWpGaD
Ceftriaxone—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—stomach cancer	3.98e-05	0.000798	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—APOA1—stomach cancer	3.92e-05	0.000787	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—IDH3B—stomach cancer	3.89e-05	0.00078	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SUCLG1—stomach cancer	3.89e-05	0.00078	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—HMOX1—stomach cancer	3.84e-05	0.000771	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PPARG—stomach cancer	3.79e-05	0.000761	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PPIA—stomach cancer	3.79e-05	0.00076	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—TP53—stomach cancer	3.68e-05	0.000739	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—SERPINA1—stomach cancer	3.65e-05	0.000732	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—ALB—stomach cancer	3.63e-05	0.000727	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—NDUFS1—stomach cancer	3.61e-05	0.000725	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—NDUFV1—stomach cancer	3.61e-05	0.000725	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	3.53e-05	0.000709	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—APOA1—stomach cancer	3.49e-05	0.0007	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—ALB—stomach cancer	3.41e-05	0.000684	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—APOA1—stomach cancer	3.39e-05	0.000681	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—IL6—stomach cancer	3.37e-05	0.000676	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—ALB—stomach cancer	3.35e-05	0.000672	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—TNF—stomach cancer	3.32e-05	0.000666	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—SPARC—stomach cancer	3.3e-05	0.000662	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—F2R—stomach cancer	3.3e-05	0.000662	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—NOS3—stomach cancer	3.26e-05	0.000654	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—PRKCB—stomach cancer	3.24e-05	0.00065	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—IRF1—stomach cancer	3.23e-05	0.000648	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PGLS—stomach cancer	3.22e-05	0.000646	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—BLVRB—stomach cancer	3.22e-05	0.000646	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—ALB—stomach cancer	3.11e-05	0.000624	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PPAP2A—stomach cancer	3.07e-05	0.000617	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PTGS2—stomach cancer	2.98e-05	0.000599	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	2.96e-05	0.000593	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—APOA1—stomach cancer	2.91e-05	0.000584	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—CD44—stomach cancer	2.81e-05	0.000563	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—ALB—stomach cancer	2.77e-05	0.000555	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CA1—stomach cancer	2.74e-05	0.00055	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—FBP1—stomach cancer	2.74e-05	0.00055	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—NDUFA2—stomach cancer	2.74e-05	0.00055	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CKB—stomach cancer	2.74e-05	0.00055	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—SERPINE1—stomach cancer	2.69e-05	0.00054	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—IL6—stomach cancer	2.68e-05	0.000537	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—RHOA—stomach cancer	2.6e-05	0.000521	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PLIN2—stomach cancer	2.58e-05	0.000517	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CA2—stomach cancer	2.51e-05	0.000503	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PGAM1—stomach cancer	2.44e-05	0.00049	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—NT5E—stomach cancer	2.44e-05	0.00049	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PPP2R1A—stomach cancer	2.39e-05	0.000479	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PLCE1—stomach cancer	2.33e-05	0.000467	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ALDH7A1—stomach cancer	2.33e-05	0.000467	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—ALB—stomach cancer	2.31e-05	0.000463	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—UMPS—stomach cancer	2.23e-05	0.000448	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—FYN—stomach cancer	2.1e-05	0.000422	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PDHA1—stomach cancer	2.08e-05	0.000417	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ECHS1—stomach cancer	2.08e-05	0.000417	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—HMOX1—stomach cancer	2e-05	0.000401	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—TYMP—stomach cancer	1.95e-05	0.000392	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—FADS1—stomach cancer	1.95e-05	0.000392	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—VEGFA—stomach cancer	1.85e-05	0.000372	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—PIK3CA—stomach cancer	1.84e-05	0.000368	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SREBF2—stomach cancer	1.83e-05	0.000367	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—RORA—stomach cancer	1.81e-05	0.000362	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PLAU—stomach cancer	1.79e-05	0.00036	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—CAV1—stomach cancer	1.75e-05	0.000352	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—MAPK3—stomach cancer	1.75e-05	0.000352	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—APOA1—stomach cancer	1.75e-05	0.000351	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ALDOB—stomach cancer	1.69e-05	0.00034	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PRKCB—stomach cancer	1.67e-05	0.000335	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—MAPK1—stomach cancer	1.67e-05	0.000335	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.6e-05	0.00032	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.59e-05	0.00032	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ALOX5—stomach cancer	1.57e-05	0.000316	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—DPYD—stomach cancer	1.55e-05	0.000311	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—APOA1—stomach cancer	1.51e-05	0.000304	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—PIK3CA—stomach cancer	1.45e-05	0.00029	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.4e-05	0.000282	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—SERPINE1—stomach cancer	1.39e-05	0.000279	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GSTT1—stomach cancer	1.37e-05	0.000275	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CYP2A6—stomach cancer	1.35e-05	0.000271	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—RHOA—stomach cancer	1.34e-05	0.000269	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—NOS3—stomach cancer	1.33e-05	0.000266	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—AKR1C3—stomach cancer	1.32e-05	0.000264	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ENO1—stomach cancer	1.28e-05	0.000257	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CD44—stomach cancer	1.14e-05	0.000228	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.1e-05	0.000221	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PPP2R1A—stomach cancer	9.67e-06	0.000194	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—VEGFA—stomach cancer	9.55e-06	0.000192	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GSTP1—stomach cancer	9.49e-06	0.00019	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—HMOX1—stomach cancer	9.36e-06	0.000188	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—MAPK3—stomach cancer	9.03e-06	0.000181	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—TYMS—stomach cancer	8.82e-06	0.000177	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GSTM1—stomach cancer	8.72e-06	0.000175	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—MAPK1—stomach cancer	8.6e-06	0.000172	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—ERCC2—stomach cancer	8.2e-06	0.000164	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—KRAS—stomach cancer	8.12e-06	0.000163	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—MTHFR—stomach cancer	7.71e-06	0.000155	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PIK3CA—stomach cancer	7.46e-06	0.00015	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—TP53—stomach cancer	7.22e-06	0.000145	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CAV1—stomach cancer	7.11e-06	0.000143	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—APOA1—stomach cancer	7.09e-06	0.000142	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—HRAS—stomach cancer	6.9e-06	0.000138	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	6.79e-06	0.000136	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PPARG—stomach cancer	6.25e-06	0.000125	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—NOS3—stomach cancer	5.37e-06	0.000108	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PTGS2—stomach cancer	4.92e-06	9.86e-05	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—PIK3CA—stomach cancer	3.02e-06	6.07e-05	CbGpPWpGaD
